• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Benzinga's Top Ratings Upgrades, Downgrades For November 22, 2021

    11/22/21 10:06:07 AM ET
    $ADBE
    $AIP
    $ALNY
    $ASPU
    Computer Software: Prepackaged Software
    Technology
    Semiconductors
    Technology
    Get the next $ADBE alert in real time by email

     

    Upgrades

    • According to Evercore ISI Group, the prior rating for Kimco Realty Corp (NYSE:KIM) was changed from In-Line to Outperform. In the third quarter, Kimco Realty showed an EPS of $0.32, compared to $0.25 from the year-ago quarter. The stock has a 52-week-high of $24.95 and a 52-week-low of $14.03. At the end of the last trading period, Kimco Realty closed at $23.87.
    • According to HSBC, the prior rating for VNET Group Inc (NASDAQ:VNET) was changed from Hold to Buy. In the third quarter, VNET Group showed an EPS of $0.03, compared to $0.06 from the year-ago quarter. The stock has a 52-week-high of $44.45 and a 52-week-low of $11.75. At the end of the last trading period, VNET Group closed at $12.97.
    • According to Goldman Sachs, the prior rating for Alnylam Pharmaceuticals Inc (NASDAQ:ALNY) was changed from Neutral to Buy. For the third quarter, Alnylam Pharmaceuticals had an EPS of $1.51, compared to year-ago quarter EPS of $1.58. At the moment, the stock has a 52-week-high of $212.00 and a 52-week-low of $120.83. Alnylam Pharmaceuticals closed at $181.00 at the end of the last trading period.
    • For Royal Gold Inc (NASDAQ:RGLD), B of A Securities upgraded the previous rating of Underperform to Neutral. Royal Gold earned $1.07 in the first quarter, compared to $0.82 in the year-ago quarter. The stock has a 52-week-high of $129.69 and a 52-week-low of $92.01. At the end of the last trading period, Royal Gold closed at $105.43.
    • For Adobe Inc (NASDAQ:ADBE), Atlantic Equities upgraded the previous rating of Neutral to Overweight. In the third quarter, Adobe showed an EPS of $3.11, compared to $2.57 from the year-ago quarter. The stock has a 52-week-high of $699.50 and a 52-week-low of $420.78. At the end of the last trading period, Adobe closed at $688.37.
    • For The Toronto-Dominion Bank (NYSE:TD), B of A Securities upgraded the previous rating of Underperform to Buy. For the third quarter, Toronto-Dominion Bank had an EPS of $1.60, compared to year-ago quarter EPS of $0.91. The current stock performance of Toronto-Dominion Bank shows a 52-week-high of $75.13 and a 52-week-low of $51.84. Moreover, at the end of the last trading period, the closing price was at $72.63.
    • According to Truist Securities, the prior rating for DoubleVerify Holdings Inc (NYSE:DV) was changed from Hold to Buy. The stock has a 52-week-high of $48.42 and a 52-week-low of $27.16. At the end of the last trading period, DoubleVerify Hldgs closed at $31.53.
    • B of A Securities upgraded the previous rating for Yamana Gold Inc (NYSE:AUY) from Neutral to Buy. In the third quarter, Yamana Gold showed an EPS of $0.07, compared to $0.10 from the year-ago quarter. The current stock performance of Yamana Gold shows a 52-week-high of $6.16 and a 52-week-low of $3.82. Moreover, at the end of the last trading period, the closing price was at $4.32.
    • William Blair upgraded the previous rating for Biomarin Pharmaceutical Inc (NASDAQ:BMRN) from Market Perform to Outperform. In the third quarter, Biomarin Pharmaceutical showed an EPS of $0.20, compared to $4.01 from the year-ago quarter. The stock has a 52-week-high of $92.56 and a 52-week-low of $71.59. At the end of the last trading period, Biomarin Pharmaceutical closed at $91.47.
    • BMO Capital upgraded the previous rating for Xcel Energy Inc (NASDAQ:XEL) from Market Perform to Outperform. In the third quarter, Xcel Energy showed an EPS of $1.13, compared to $1.14 from the year-ago quarter. At the moment, the stock has a 52-week-high of $72.94 and a 52-week-low of $57.23. Xcel Energy closed at $65.10 at the end of the last trading period.

    See all analyst ratings upgrades.

     

    Downgrades

    • According to Northland Capital Markets, the prior rating for Casa Systems Inc (NASDAQ:CASA) was changed from Outperform to Market Perform. Casa Systems earned $0.05 in the third quarter, compared to $0.07 in the year-ago quarter. The stock has a 52-week-high of $13.15 and a 52-week-low of $4.80. At the end of the last trading period, Casa Systems closed at $5.41.
    • For Ventas Inc (NYSE:VTR), SMBC Nikko downgraded the previous rating of Outperform to Neutral. Ventas earned $0.73 in the third quarter, compared to $0.75 in the year-ago quarter. The stock has a 52-week-high of $61.09 and a 52-week-low of $45.40. At the end of the last trading period, Ventas closed at $51.35.
    • According to Bradesco Corretora, the prior rating for StoneCo Ltd (NASDAQ:STNE) was changed from Neutral to Underperform. For the third quarter, StoneCo had an EPS of $0.09, compared to year-ago quarter EPS of $0.18. The current stock performance of StoneCo shows a 52-week-high of $95.12 and a 52-week-low of $19.07. Moreover, at the end of the last trading period, the closing price was at $19.13.
    • For PagSeguro Digital Ltd (NYSE:PAGS), Bradesco Corretora downgraded the previous rating of Outperform to Neutral. In the third quarter, PagSeguro Digital showed an EPS of $0.24, compared to $0.15 from the year-ago quarter. The current stock performance of PagSeguro Digital shows a 52-week-high of $62.83 and a 52-week-low of $29.64. Moreover, at the end of the last trading period, the closing price was at $29.72.
    • According to Roth Capital, the prior rating for Aspen Group Inc (NASDAQ:ASPU) was changed from Buy to Neutral. In the first quarter, Aspen Group showed an EPS of $0.03, compared to $0.00 from the year-ago quarter. The current stock performance of Aspen Group shows a 52-week-high of $12.80 and a 52-week-low of $4.05. Moreover, at the end of the last trading period, the closing price was at $4.13.
    • BTIG downgraded the previous rating for Teladoc Health Inc (NYSE:TDOC) from Buy to Neutral. In the third quarter, Teladoc Health showed an EPS of $0.53, compared to $0.13 from the year-ago quarter. The current stock performance of Teladoc Health shows a 52-week-high of $308.00 and a 52-week-low of $116.89. Moreover, at the end of the last trading period, the closing price was at $116.99.
    • For Activision Blizzard Inc (NASDAQ:ATVI), MKM Partners downgraded the previous rating of Neutral to Sell. Activision Blizzard earned $0.72 in the third quarter, compared to $0.71 in the year-ago quarter. The stock has a 52-week-high of $104.53 and a 52-week-low of $60.90. At the end of the last trading period, Activision Blizzard closed at $62.38.
    • For Blink Charging Co (NASDAQ:BLNK), Cowen & Co. downgraded the previous rating of Outperform to Market Perform. In the third quarter, Blink Charging showed an EPS of $0.36, compared to $0.12 from the year-ago quarter. The current stock performance of Blink Charging shows a 52-week-high of $64.50 and a 52-week-low of $14.95. Moreover, at the end of the last trading period, the closing price was at $43.08.
    • According to Exane BNP Paribas, the prior rating for Equifax Inc (NYSE:EFX) was changed from Outperform to Neutral. For the third quarter, Equifax had an EPS of $1.85, compared to year-ago quarter EPS of $1.87. The current stock performance of Equifax shows a 52-week-high of $292.11 and a 52-week-low of $161.87. Moreover, at the end of the last trading period, the closing price was at $288.86.
    • According to Keybanc, the prior rating for Westlake Chemical Corp (NYSE:WLK) was changed from Overweight to Sector Weight. In the third quarter, Westlake Chemical showed an EPS of $4.69, compared to $0.64 from the year-ago quarter. The current stock performance of Westlake Chemical shows a 52-week-high of $106.47 and a 52-week-low of $72.83. Moreover, at the end of the last trading period, the closing price was at $97.72.
    • According to Keybanc, the prior rating for Olin Corp (NYSE:OLN) was changed from Overweight to Sector Weight. For the third quarter, Olin had an EPS of $2.38, compared to year-ago quarter EPS of $0.23. The stock has a 52-week-high of $64.76 and a 52-week-low of $20.89. At the end of the last trading period, Olin closed at $60.22.
    • Keybanc downgraded the previous rating for Celanese Corp (NYSE:CE) from Overweight to Sector Weight. Celanese earned $4.82 in the third quarter, compared to $1.95 in the year-ago quarter. The stock has a 52-week-high of $174.04 and a 52-week-low of $115.42. At the end of the last trading period, Celanese closed at $165.74.

    See all analyst ratings downgrades.

     

    Initiations

    • With an Outperform rating, Credit Suisse initiated coverage on Rent the Runway Inc (NASDAQ:RENT).  Rent the Runway earned $0.29 in the second quarter, compared to $0.17 in the year-ago quarter.
    • Goldman Sachs initiated coverage on Informatica Inc (NYSE:INFA) with a Buy rating. Informatica earned $0.18 in the second quarter, compared to $0.35 in the year-ago quarter.
    • With a Neutral rating, Goldman Sachs initiated coverage on IonQ Inc (NYSE:IONQ).
    • JP Morgan initiated coverage on Blackstone Secured Lending Fund (NYSE:BXSL) with a Neutral rating. 
    • Keybanc initiated coverage on Rent the Runway Inc (NASDAQ:RENT) with an Overweight rating In the second quarter, Rent the Runway showed an EPS of $0.29, compared to $0.17 from the year-ago quarter.

    See all analyst ratings initiations.

    Get the next $ADBE alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ADBE
    $AIP
    $ALNY
    $ASPU

    CompanyDatePrice TargetRatingAnalyst
    Xcel Energy Inc.
    $XEL
    2/13/2026$89.00Neutral → Buy
    UBS
    Fluence Energy Inc.
    $FLNC
    2/10/2026$24.00Hold → Buy
    Jefferies
    Cushman & Wakefield Ltd.
    $CWK
    2/9/2026$19.00Peer Perform → Outperform
    Wolfe Research
    StoneCo Ltd.
    $STNE
    2/9/2026$22.00Buy
    BTIG Research
    Westlake Corporation
    $WLK
    2/9/2026$88.00Outperform → Neutral
    Mizuho
    Stoke Therapeutics Inc.
    $STOK
    2/5/2026$60.00Buy
    Guggenheim
    Celanese Corporation
    $CE
    2/5/2026$86.00Hold → Buy
    Jefferies
    Allbirds Inc.
    $BIRD
    2/4/2026Buy → Hold
    Maxim Group
    More analyst ratings

    $ADBE
    $AIP
    $ALNY
    $ASPU
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for GIVLAARI issued to ALNYLAM PHARMS INC

    Submission status for ALNYLAM PHARMS INC's drug GIVLAARI (SUPPL-7) with active ingredient GIVOSIRAN SODIUM has changed to 'Approval' on 04/29/2024. Application Category: NDA, Application Number: 212194, Application Classification: Labeling

    4/30/24 1:44:03 PM ET
    $ALNY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for OXLUMO issued to ALNYLAM PHARMS INC

    Submission status for ALNYLAM PHARMS INC's drug OXLUMO (SUPPL-4) with active ingredient LUMASIRAN SODIUM has changed to 'Approval' on 09/19/2023. Application Category: NDA, Application Number: 214103, Application Classification: Labeling

    9/20/23 2:36:38 PM ET
    $ALNY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    June 29, 2023 - FDA Approves First Gene Therapy for Adults with Severe Hemophilia A

    For Immediate Release: June 29, 2023 Today, the U.S. Food and Drug Administration approved Roctavian, an adeno-associated virus vector-based gene therapy for the treatment of adults with severe hemophilia A without pre-existing antibodies to adeno-associated virus serotype 5 detected by an FDA-approved test. “Hereditary hemophilia A is a potentially serious bleeding disorder. Severe cases of hemophilia A can ca

    6/29/23 6:02:12 PM ET
    $BMRN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ADBE
    $AIP
    $ALNY
    $ASPU
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    EVP, Chief Legal Officer Houston Julia A was granted 4,119 shares and covered exercise/tax liability with 2,614 shares, increasing direct ownership by 9% to 17,446 units (SEC Form 4)

    4 - EQUIFAX INC (0000033185) (Issuer)

    2/12/26 4:08:18 PM ET
    $EFX
    Finance: Consumer Services
    Finance

    EVP, Chief Product Officer Mao Cecilia was granted 1,374 shares and covered exercise/tax liability with 918 shares, increasing direct ownership by 6% to 8,223 units (SEC Form 4)

    4 - EQUIFAX INC (0000033185) (Issuer)

    2/12/26 4:08:19 PM ET
    $EFX
    Finance: Consumer Services
    Finance

    EVP, CFO & COO Gamble John W Jr was granted 10,983 shares and covered exercise/tax liability with 7,121 shares, increasing direct ownership by 6% to 63,421 units (SEC Form 4)

    4 - EQUIFAX INC (0000033185) (Issuer)

    2/12/26 4:08:15 PM ET
    $EFX
    Finance: Consumer Services
    Finance

    $ADBE
    $AIP
    $ALNY
    $ASPU
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Xcel Energy upgraded by UBS with a new price target

    UBS upgraded Xcel Energy from Neutral to Buy and set a new price target of $89.00

    2/13/26 8:27:11 AM ET
    $XEL
    Power Generation
    Utilities

    Fluence upgraded by Jefferies with a new price target

    Jefferies upgraded Fluence from Hold to Buy and set a new price target of $24.00

    2/10/26 7:57:53 AM ET
    $FLNC
    Industrial Machinery/Components
    Miscellaneous

    Cushman & Wakefield upgraded by Wolfe Research with a new price target

    Wolfe Research upgraded Cushman & Wakefield from Peer Perform to Outperform and set a new price target of $19.00

    2/9/26 9:29:28 AM ET
    $CWK
    Real Estate
    Finance

    $ADBE
    $AIP
    $ALNY
    $ASPU
    SEC Filings

    View All

    SEC Form 6-K filed by VNET Group Inc.

    6-K - VNET Group, Inc. (0001508475) (Filer)

    2/13/26 7:15:28 AM ET
    $VNET
    Computer Software: Programming Data Processing
    Technology

    SEC Form S-3 filed by Arteris Inc.

    S-3 - Arteris, Inc. (0001667011) (Filer)

    2/12/26 5:22:41 PM ET
    $AIP
    Semiconductors
    Technology

    SEC Form S-8 filed by Arteris Inc.

    S-8 - Arteris, Inc. (0001667011) (Filer)

    2/12/26 5:20:23 PM ET
    $AIP
    Semiconductors
    Technology

    $ADBE
    $AIP
    $ALNY
    $ASPU
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Financial Officer Bercovich Michael bought $50,392 worth of shares (65,333 units at $0.77), increasing direct ownership by 53% to 188,563 units (SEC Form 4)

    4 - Blink Charging Co. (0001429764) (Issuer)

    12/12/25 6:08:54 PM ET
    $BLNK
    Industrial Specialties
    Consumer Discretionary

    President and CEO Battaglia Michael C. bought $25,000 worth of shares (33,333 units at $0.75), increasing direct ownership by 14% to 267,095 units (SEC Form 4)

    4 - Blink Charging Co. (0001429764) (Issuer)

    12/12/25 6:07:33 PM ET
    $BLNK
    Industrial Specialties
    Consumer Discretionary

    CEO & President Richardson Scott A bought $158,042 worth of shares (3,800 units at $41.59), increasing direct ownership by 6% to 70,449 units (SEC Form 4)

    4 - Celanese Corp (0001306830) (Issuer)

    12/12/25 4:19:38 PM ET
    $CE
    Major Chemicals
    Industrials

    $ADBE
    $AIP
    $ALNY
    $ASPU
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    VNET Appoints New Officer to Finance Leadership Team

    BEIJING, Feb. 13, 2026 /PRNewswire/ -- VNET Group, Inc. (NASDAQ:VNET) ("VNET" or the "Company"), a leading carrier- and cloud-neutral internet data center services provider in China, today announced the appointment of Mr. Peter Zhihua Zhang as Senior Vice President, Operational Finance, effective immediately. Mr. Zhang will be responsible for the Company's financial operations and is authorized to review and approve the Company's financial statements and related filings for SEC and Nasdaq compliance purposes, as applicable. Mr. Zhang will also serve as the Company's "principal accounting officer" in accordance with applicable U.S. federal securities laws, SEC rules, and Nasdaq requirements.

    2/13/26 7:00:00 AM ET
    $VNET
    Computer Software: Programming Data Processing
    Technology

    Arteris Network-on-Chip Technology Achieves Deployment Milestone of 4 Billion Chips and Chiplets

    CAMPBELL, Calif., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Arteris, Inc. (NASDAQ:AIP), a leading provider of semiconductor technology for accelerating innovation in the AI era, today announced that its technology has shipped in more than 4 billion devices, signifying important growth in enabling the underlying data movement for AI-era chips and chiplets. While Arteris system IP has long been deployed in high-volume devices, from automotive systems to consumer devices, recent growth has been driven by increased adoption in AI-enabled systems, where Arteris technology is particularly suited for rising compute density, energy efficiency requirements, chiplet integration, and ever-growing system com

    2/12/26 4:10:00 PM ET
    $AIP
    Semiconductors
    Technology

    Olin to Take a Fourth Quarter 2025 Charge Following Verdict in Shintech v. Olin Litigation

    CLAYTON, Mo., Feb. 12, 2026 /PRNewswire/ -- Olin Corporation (NYSE:OLN), a leading global manufacturer and distributor of chemical products, today issued an update following a recent verdict in a litigation matter filed by Shintech Incorporated ("Shintech") against Olin Corporation and its wholly owned subsidiary, Blue Cube Operations LLC (collectively, "Olin"). In April 2023, Shintech filed a lawsuit seeking damages against Olin. The litigation involved a pricing dispute between Shintech and Olin, a 2023 maintenance turnaround of a vinyl chloride monomer (VCM) plant and a dis

    2/12/26 4:05:00 PM ET
    $OLN
    Major Chemicals
    Industrials

    $ADBE
    $AIP
    $ALNY
    $ASPU
    Leadership Updates

    Live Leadership Updates

    View All

    VNET Appoints New Officer to Finance Leadership Team

    BEIJING, Feb. 13, 2026 /PRNewswire/ -- VNET Group, Inc. (NASDAQ:VNET) ("VNET" or the "Company"), a leading carrier- and cloud-neutral internet data center services provider in China, today announced the appointment of Mr. Peter Zhihua Zhang as Senior Vice President, Operational Finance, effective immediately. Mr. Zhang will be responsible for the Company's financial operations and is authorized to review and approve the Company's financial statements and related filings for SEC and Nasdaq compliance purposes, as applicable. Mr. Zhang will also serve as the Company's "principal accounting officer" in accordance with applicable U.S. federal securities laws, SEC rules, and Nasdaq requirements.

    2/13/26 7:00:00 AM ET
    $VNET
    Computer Software: Programming Data Processing
    Technology

    Cushman & Wakefield Hires Damla Gerhart as Executive Regional Director, Midwest Region

    Gerhart will lead operations and strategic growth across Midwest markets of Chicago, Cincinnati, Columbus, Detroit, Indianapolis, Kansas City, Minneapolis and St. Louis Cushman & Wakefield (NYSE:CWK), a leading global real estate services firm, announced today the appointment of Damla Gerhart as Executive Regional Director of the Midwest Region, effective March 2. In her new role, Gerhart will oversee Cushman & Wakefield's operations and strategic growth initiatives in the Midwest which includes Chicago, Cincinnati, Columbus, Detroit, Indianapolis, Kansas City, Minneapolis and St. Louis. In this role, she will lead client service delivery, talent development and recruiting, while drivin

    2/5/26 3:08:00 PM ET
    $CWK
    Real Estate
    Finance

    Cushman & Wakefield Hires Joey Verrant as Chief Operating Officer of Asset Services Multifamily

    Cushman & Wakefield (NYSE:CWK), a leading global real estate services firm, is pleased to announce that Joey Verrant has joined the company as Chief Operating Officer of Asset Services Multifamily, effective today. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260122534427/en/Joey Verrant In this role, Verrant will partner closely with Asset Services Multifamily leadership to drive performance and service excellence in operations across all managed properties. He will also be instrumental in shaping and executing strategies, ensuring robust controls and fostering a high-performance culture that supports organizational growth an

    1/22/26 9:00:00 AM ET
    $CWK
    Real Estate
    Finance

    $ADBE
    $AIP
    $ALNY
    $ASPU
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Eos Energy Enterprises Inc.

    SC 13D/A - Eos Energy Enterprises, Inc. (0001805077) (Subject)

    12/17/24 2:48:02 PM ET
    $EOSE
    Industrial Machinery/Components
    Miscellaneous

    Amendment: SEC Form SC 13D/A filed by MoneyLion Inc.

    SC 13D/A - MONEYLION INC. (0001807846) (Subject)

    12/10/24 5:27:46 PM ET
    $ML
    Finance: Consumer Services
    Finance

    Amendment: SEC Form SC 13G/A filed by Celanese Corporation

    SC 13G/A - Celanese Corp (0001306830) (Subject)

    12/6/24 12:11:25 PM ET
    $CE
    Major Chemicals
    Industrials

    $ADBE
    $AIP
    $ALNY
    $ASPU
    Financials

    Live finance-specific insights

    View All

    Olin to Take a Fourth Quarter 2025 Charge Following Verdict in Shintech v. Olin Litigation

    CLAYTON, Mo., Feb. 12, 2026 /PRNewswire/ -- Olin Corporation (NYSE:OLN), a leading global manufacturer and distributor of chemical products, today issued an update following a recent verdict in a litigation matter filed by Shintech Incorporated ("Shintech") against Olin Corporation and its wholly owned subsidiary, Blue Cube Operations LLC (collectively, "Olin"). In April 2023, Shintech filed a lawsuit seeking damages against Olin. The litigation involved a pricing dispute between Shintech and Olin, a 2023 maintenance turnaround of a vinyl chloride monomer (VCM) plant and a dis

    2/12/26 4:05:00 PM ET
    $OLN
    Major Chemicals
    Industrials

    Arteris Announces Financial Results for the Fourth Quarter and Full Year 2025 and Estimated First Quarter and Full Year 2026 Guidance

    CAMPBELL, Calif., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Arteris, Inc. (NASDAQ:AIP), a leading provider of semiconductor technology for accelerating innovation in the AI era, today announced financial results for the fourth quarter and year ended December 31, 2025 and provided estimated first quarter and full year 2026 guidance. "In the fourth quarter of 2025, we again delivered strong financial results, including a new record of Annual Contract Value plus royalties reaching $83.6 million, representing 28% year-over-year growth. During the quarter, our customers surpassed the milestone of more than four billion systems shipped with SoCs connected by Arteris System IP, and we enjoyed royalty gr

    2/12/26 4:05:00 PM ET
    $AIP
    Semiconductors
    Technology

    Alnylam Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Highlights Recent Period Progress

    − Achieved Fourth Quarter and Full Year 2025 Global Net Product Revenues of $995 Million and $2,987 Million, Respectively, Representing 121% and 81% Growth Compared to Same Periods in 2024 – − Attained GAAP and non-GAAP Profitability for Full Year 2025, with Sustainable Growth in Operating Income Expected – − Launched "Alnylam 2030" Strategy Focused on Scaling Alnylam through Durable ATTR Leadership, Long-Term Sustainable Innovation, and Exceptional Financial Results – − Announced 2026 Pipeline Goals, Including 4 Clinical Readouts, 3 Ongoing Pivotal Studies, 3 Phase 2 Study Initiations, and 3+ New IND Filings – − Reiterates Net Product Sales Guidance and Provides Additional 2026 Fin

    2/12/26 8:00:00 AM ET
    $ALNY
    Biotechnology: Pharmaceutical Preparations
    Health Care